Dolutegravir-based monotherapy or dual therapy maintains a high proportion of viral suppression even in highly experienced HIV-1-infected patients
暂无分享,去创建一个
L. Hocqueloux | T. Prazuck | J. Guinard | J. Buret | C. Gubavu | V. Avettand-Fenoël | M. Niang | C. Mille